Verano Holdings (VRNO) Assets Average (2022 - 2026)
Verano Holdings (VRNO) posted quarterly Assets Average of $1.7 billion for Q1 2026, down 12.95% year-over-year from $2.0 billion in Q1 2025, and down 5.92% quarter-over-quarter from $1.8 billion in Q4 2025.
Verano Holdings (VRNO) Assets Average (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Assets Average for 5 consecutive years, with $1.7 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 12.95% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (down 12.95% YoY), while the FY2025 annual figure was $1.9 billion, down 13.38% from the prior year.
- Assets Average eased to $1.7 billion in Q1 2026 per VRNO's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Assets Average topped out at $2.6 billion in Q3 2022 and bottomed at $1.7 billion in Q1 2026.
- Historically, Assets Average has averaged $2.2 billion across 5 years, with a median of $2.3 billion in 2024.
- Annual changes were most pronounced in 2024 — Assets Average declined 2.75% — and 2025, when it slipped 15.08%.
- Verano Holdings' Assets Average stood at $2.5 billion in 2022, then dropped by 6.88% to $2.3 billion in 2023, then retreated by 7.81% to $2.2 billion in 2024, then dropped by 14.9% to $1.8 billion in 2025, then retreated by 5.92% to $1.7 billion in 2026.
- Business Quant data shows VRNO's Assets Average at $1.7 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Verano Holdings | 438.82 Mn | 353.62 Mn | 99.70 Mn | 1.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Bn |
| Mar 31, 2026 | 1.72 Bn |
| Dec 31, 2025 | 1.83 Bn |
| Sep 30, 2025 | 1.93 Bn |
| Jun 30, 2025 | 1.96 Bn |
| Mar 31, 2025 | 1.98 Bn |
| Dec 31, 2024 | 2.15 Bn |
| Sep 30, 2024 | 2.28 Bn |
| Jun 30, 2024 | 2.28 Bn |
| Mar 31, 2024 | 2.32 Bn |
| Dec 31, 2023 | 2.34 Bn |
| Sep 30, 2023 | 2.35 Bn |
| Jun 30, 2023 | 2.36 Bn |
| Mar 31, 2023 | 2.38 Bn |
| Dec 31, 2022 | 2.51 Bn |
| Sep 30, 2022 | 2.61 Bn |